Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Gets $17M Contract from FDA for Food Safety Tools

NEW YORK (GenomeWeb News) – Illumina today said that it has received a $17 million contract from the US Food and Drug Administration to provide sequencing systems and reagents for food safety testing.

Under the five-year contract, Illumina will supply its MiSeq systems and reagents for performing whole-genome analysis on produce and produce-related environmental Salmonella and shigatoxigenic E. coli isolates.

Illumina said in a statement that the FDA already has several MiSeq systems deployed in its labs and is building its existing capacity as part of a proof-of-concept initiative. In addition, it said in the short-term the FDA is looking to collect data that is crucial to source-tracking Salmonella that may be involved in future produce-related outbreaks.

Sequence data collected at the FDA labs will be uploaded in real-time to the National Center for Biotechnology Information curated database and will provide early proof of concept for using whole-genome sequencing for pathogen detection, identification and traceback, said Illumina.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.